Related posts

TSX climbs, Wall Street mixedRally pausesMild Monday amid earnings
Investor Insights

This summary was created by AI, based on 10 opinions in the last 12 months.

Medtronic Inc (MDT) has experienced a tumultuous journey, transitioning from a market favorite to trading near its 10-year low. However, recent product launches have revived interest in the stock, highlighted by a strong quarterly performance that boosted investor sentiment. Many experts underscore the company's strong management and emphasize the positive trends in the medical device sector, particularly driven by increasing procedure volumes and an aging population. Furthermore, the stock's valuation appears attractive at a forward P/E of 15.9, positioned between its historical range of 13.4x to 22.8x. Despite some concerns about its growth trajectory and operational challenges, the potential in medical solutions offers a promising outlook, along with ongoing advancements such as AI in their devices and strategic partnerships with companies like Nvidia.

Consensus
Positive
Valuation
Fair Value
BUY

It's been lost in the wilderness for years, but has had a bunch of successful product launches and the stock is now cheap.

BUY

Well-managed. She likes this sector, medical devices, becuse procedures are picking up, and aging demographics are another tailwind.

DON'T BUY

It's gone from a market darling to loser, trading at a 10-year low now. It's a show-me stock, though cheap at 15x PE. If the company can grow 5%, maybe it's worth buying. They need to work out some issues first.

HOLD

Lots of development can happen in the area of medical devices. Great business. Keeps people out of hospitals. These companies should do well over the next while, as medical solutions move away from being drug-centred. Prefers SYK.

BUY

They just delivered a fantastic quarter recently and has rallied 6% since then as the market rotates to healthcare.

BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

MDT is a mature MedTech company that is now trading at a 15.9x Forward P/E. Over the last few years, MDT’s valuation has ranged from 13.4x to 22.8x Forward P/E, we think the current valuation is fairly attractive. MDT’s share price has performed well recently due to a combination of 1) investors moving to defensive sectors with stable cash flows 2) MDT reported very solid earnings with a 5.3% organic growth rate.
Unlock Premium - Try 5i Free

BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

MDT is a mature MedTech company that is now trading at a 15.9x Forward P/E. Over the last few years, MDT’s valuation has ranged from 13.4x to 22.8x Forward P/E, we think the current valuation is fairly attractive. MDT’s share price has performed well recently due to a combination of 1) investors moving to defensive sectors with stable cash flows 2) MDT reported very solid earnings with a 5.3% organic growth rate.
Unlock Premium - Try 5i Free

BUY

They use AI in their medical devices; have lots of good devices.

PAST TOP PICK
(A Top Pick Sep 01/23, Up 3%)

It has neuroscience products, robotic surgery products, etc. People are getting back into having surgeries so it can raise prices. He is looking for better returns in the next while.

COMMENT
Is one of the biggest beneficiaries of partnering with Nvidia

They partner with Nvidia aggressively, as in MDT's effective colonoscopy machine.

PAST TOP PICK
(A Top Pick Jan 13/23, Up 10%)

Demand for healthcare electronics not slowing down. Business continues to perform. However, recently sold shares - thinks better opportunities elsewhere. Not allocating capital in the best possible way. 

WEAK BUY

Medical devices, not pharma. Important area that keeps people out of expensive hospitals, improves quality of life, and reduces reliance on drugs. Great advances, which will grow over the years. You want to be in this area. He owns SYK and JNJ in the space.

TOP PICK

Medical technology demand growing.
Surgery demand growing after the end of Covid-19.
Current share price a good buying opportunity.
Large exposure to Asia market.
Aging population also a good factor. 

SELL ON STRENGTH

Ugly chart. Street opinion is a blend of Buy and Hold at these levels. She waits to see a trend reversal before getting in. Fundamentally, 9/10. Diverse portfolio, likes the positioning. Healthcare is great before a recession, but better names out there. Ride it out until you can break even.

(Analysts’ price target is $94.00)
BUY

It reports next week. A great value name. Medtronic has been focusing on organic growth. 

Showing 1 to 15 of 121 entries

Medtronic Inc(MDT-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 7

Neutral - Hold Signals / Votes : 1

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 9

Stockchase rating for Medtronic Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Medtronic Inc(MDT-N) Frequently Asked Questions

What is Medtronic Inc stock symbol?

Medtronic Inc is a American stock, trading under the symbol MDT-N on the New York Stock Exchange (MDT). It is usually referred to as NYSE:MDT or MDT-N

Is Medtronic Inc a buy or a sell?

In the last year, 9 stock analysts published opinions about MDT-N. 7 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Medtronic Inc.

Is Medtronic Inc a good investment or a top pick?

Medtronic Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Medtronic Inc.

Why is Medtronic Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Medtronic Inc worth watching?

9 stock analysts on Stockchase covered Medtronic Inc In the last year. It is a trending stock that is worth watching.

What is Medtronic Inc stock price?

On 2025-03-14, Medtronic Inc (MDT-N) stock closed at a price of $93.03.